Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Spi-C transcription factor (SPIC) is an ETS-family transcriptional regulator, expressed primarily in B lymphocytes and red pulp macrophages. It plays a critical role in the development of red pulp macrophages necessary for iron homeostasis, and in the recycling of red blood cells. In B cells, Spi-C acts as a transcriptional repressor and may antagonize the activities of PU.1 and Spi-B, both of which are key drivers of B cell differentiation and antibody-mediated immune responses. It is also involved in the differentiation and function of osteoclasts, promoting bone resorption and responding to signals such as RANKL. Mutation or deletion of Spic affects immune cell development, and deficiencies can be associated with combined immunodeficiency syndromes. It is not currently considered a direct therapeutic target and no interacting drugs or defined safety concerns are reported.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Spi-C transcription factor (SPIC).